Retinal fundus in screening PD, page-7

Hi Pivalde,

I have been on this stock from the days of Prana. Personally, I lost hope their for a while that this Company would ever be successful. After the positive results from the Primate study, It has reinvigorated my confidence in Alterity. My personal view is we will be successful in both trials this year. I think ATH has learnt from past mistakes during trials. They have also recruited the right People like Dr Stamler to help get the drug over the line with the FDA. Another big factor at play is the "Open Label Study" running concurrently with the "Double Blinded Placebo Study". Its a genius move to have them running almost side by side. If the "Open Label Study" results are as good if not better than the Primates Study, I believe its an absolute game changer and its sets up an interesting conclusion for the "Double Blinded Placebo" results due next January.

What are your thoughts, do you believe we will achieve successful outcomes for ATH this year?

Stockman.